Health Trials

MicroRNA as Markers in Testicular Cancer

ConditionsTesticular Germ Cell CancerSeminomaNon-Seminoma Testicular CancerStage I Testicular CancerStage II Testicular CancerStage III Testicular CancerStage IV Testicular CancerRelapse Testicular Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18-70
SponsorHaukeland University Hospital

About this trial

The main objective of this study is establish the performance of miR371 in management of testicular cancer

Eligibility criteria

Qualifiers

Patients with suspected testicular cancer, referred to orchiectomy.

Patients diagnosed with testicular germ cell cancer.

Age 18-70 years of age.

Must be able receive information and to consent.

Disqualifiers

Other prior or concomitant malignancy (other than testicular cancer).

Other diseases or conditions that hinder the ability to receive information and to participate in follow-up procedures.

Trial design

Treatments tested in this trial

  • Biomarker analysis

Treatment groups

No treatment groups listed

Sponsors and collaborators

Haukeland University Hospital

Lead sponsor

Karolinska University Hospital

Collaborator

Sahlgrenska University Hospital

Collaborator

Helse Fonna

Collaborator

University Hospital of North Norway

Collaborator

Oslo University Hospital

Collaborator

Source ClinicalTrials.gov